IDEXX Laboratories Inc

US · IDXX #543 by market cap Listed 1970

506.67 -8.74 -1.70%

Live - 5344 symbols - heartbeat 132s ago · 2026-10-08 05:47

Pre-market 506.00 -0.13%

After-hours 507.01 +0.07%

Market cap: 39.92B
P/E (TTM): 35.61
P/B: 24.75
EPS: 13.08
Div yield: 0.00%
52W pos: 2%

Reader sentiment Are you bullish or bearish on IDXX?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Financial Health how this is computed

Good

Altman Z-Score is 19.11, above the 3.0 "safe zone" threshold.
Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.

Revenue annual, last 8 years

Latest year +10.42% YoY

Margins

Gross margin: 61.80%
Operating margin: 31.60%
Net margin: 24.62%

Key ratios & quality

Enterprise value: 40.61B
PEG ratio: 2.23
Altman Z-Score: 19.11

PEG uses trailing P/E against the 3-year net income growth rate (15.98%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.

Income statement

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	2.21B	2.41B	2.71B	3.22B	3.37B	3.66B	3.90B	4.30B
Gross profit	1.24B	1.37B	1.57B	1.89B	2.00B	2.19B	2.38B	2.66B
Selling & admin expenses	632.34M	679.51M	735.27M	796.40M	850.75M	901.89M	1.03B	1.05B
Research & development	117.86M	133.19M	141.25M	161.01M	254.82M	190.95M	219.79M	251.21M
Operating profit	491.34M	552.85M	694.52M	932.03M	898.77M	1.10B	1.13B	1.36B
Pretax profit	457.74M	522.22M	661.99M	902.65M	859.97M	1.06B	1.11B	1.32B
Tax	80.70M	94.43M	79.85M	157.81M	180.88M	216.13M	221.96M	264.73M
Net profit	377.05M	427.79M	582.13M	744.84M	679.09M	845.04M	887.87M	1.06B
Basic EPS	4	5	7	9	8	10	11	13
Diluted EPS	4.26	4.89	6.71	8.60	8.03	10.06	10.67	13.08

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Revenue	998.43M	1.11B	1.11B	1.09B	1.14B	1.22B
Gross profit	623.38M	694.73M	683.35M	658.11M	722.74M	779.09M
Selling & admin expenses	247.78M	259.79M	265.09M	275.68M	294.37M	288.09M
Research & development	59.06M	61.90M	63.42M	66.83M	65.79M	65.43M
Operating profit	316.53M	373.05M	354.85M	315.61M	362.59M	425.57M
Pretax profit	310.08M	362.35M	344.77M	306.98M	355.44M	417.22M
Tax	67.41M	68.36M	70.16M	58.79M	77.00M	78.81M
Net profit	242.68M	293.99M	274.61M	248.19M	278.45M	338.41M
Basic EPS	3	4	3	3	4	4
Diluted EPS	2.96	3.63	3.40	3.08	3.47	4.27

Balance sheet

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Total current assets	654.17M	679.64M	1.06B	955.66M	1.10B	1.50B	1.40B	1.41B
Cash & ST investments	123.79M	90.33M	383.93M	144.45M	112.55M	453.93M	288.27M	180.07M
Inventory	173.30M	195.02M	209.87M	269.03M	367.82M	380.28M	381.88M	377.76M
Total assets	1.54B	1.83B	2.29B	2.44B	2.75B	3.26B	3.29B	3.35B
Total current liabilities	770.44M	725.34M	582.76M	763.58M	1.24B	951.55M	1.07B	1.15B
Short-term debt	398.94M	304.05M	67.72M	168.43M	674.41M	344.80M	439.33M	500.07M
Long-term debt	601.35M	698.91M	858.49M	775.21M	694.39M	622.88M	449.79M	374.84M
Total liabilities	1,546,582,000.00	1,654,650,000.00	1,661,766,000.00	1,747,211,000.00	2,138,028,000.00	1,775,395,000.00	1,698,130,000.00	1,745,376,000.00
Total equity	-9.23M	177.83M	632.80M	689.99M	608.74M	1.48B	1.60B	1.61B
Retained earnings	1.17B	1.60B	2.18B	2.92B	3.60B	4.44B	5.33B	6.39B

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Total current assets	1.32B	1.36B	1.48B	1.41B	1.45B	1.51B
Cash & ST investments	163.97M	164.59M	208.17M	180.07M	200.53M	196.93M
Inventory	395.99M	392.58M	391.56M	377.76M	382.40M	391.58M
Total assets	3.21B	3.33B	3.39B	3.35B	3.39B	3.44B
Total current liabilities	1.14B	1.22B	1.25B	1.15B	1.30B	1.29B
Short-term debt	512.56M	679.82M	631.64M	500.07M	706.85M	695.71M
Long-term debt	449.80M	449.81M	374.83M	374.84M	299.85M	299.87M
Total liabilities	1,765,676,000.00	1,871,967,000.00	1,825,526,000.00	1,745,376,000.00	1,829,394,000.00	1,829,760,000.00
Total equity	1.45B	1.46B	1.56B	1.61B	1.56B	1.61B
Retained earnings	5.58B	5.87B	6.14B	6.39B	6.67B	7.01B

Cash flow

Line item	2018	2019	2020	2021	2022	2023	2024	2025
Operating cash flow	400.08M	459.16M	648.06M	755.55M	542.98M	906.51M	929.00M	1.18B
Depreciation & amortization	83.18M	88.01M	96.00M	104.60M	111.90M	114.91M	129.94M	145.18M
Free cash flow	277.15M	303.93M	540.19M	636.00M	384.15M	772.88M	798.08M	1.04B
Dividends paid	--	--	--	--	--	--	--	--
Stock buybacks / issuance	-369.32M	-301.66M	-182.82M	-746.78M	-819.71M	-71.92M	-837.03M	-1.22B
Ending cash balance	123.79M	90.33M	383.93M	144.45M	112.55M	453.93M	288.27M	180.07M

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
Operating cash flow	237.96M	185.74M	402.34M	355.76M	266.25M	347.16M
Depreciation & amortization	34.06M	35.77M	36.63M	38.72M	37.68M	41.05M
Free cash flow	207.94M	151.64M	357.88M	326.13M	232.46M	320.62M
Dividends paid	--	--	--	--	--	--
Stock buybacks / issuance	-400.89M	-338.11M	-240.20M	-237.77M	-351.04M	-346.80M
Ending cash balance	163.97M	164.59M	208.17M	180.07M	200.53M	196.93M

Returns & efficiency

Line item	2018	2019	2020	2021	2022	2023	2024	2025
ROE %	--	509.31	143.73	112.68	104.58	80.74	57.66	66.20
ROA %	23.20	25.39	28.19	31.48	26.20	28.14	27.10	31.89
ROIC %	--	40.45	42.34	45.83	37.36	37.73	35.16	42.15
5-year avg ROE %	--	--	--	--	--	190.21	99.88	84.37
EBIT margin %	22.25	22.99	25.68	29.00	26.72	30.12	29.28	31.67
FCF / sales %	12.52	12.63	19.96	19.78	11.41	21.11	20.48	24.25
Current ratio	0.85	0.94	1.82	1.25	0.89	1.57	1.31	1.23
Quick ratio	0.51	0.55	1.30	0.75	0.49	1.03	0.80	0.76
Debt / assets	65.07	58.41	43.72	42.30	53.52	32.74	29.97	29.13
LT debt / equity	--	431.83	148.01	125.01	130.70	48.67	34.33	29.65
Interest coverage	14.17	17.82	20.98	31.28	22.58	26.52	36.57	35.08
Revenue CAGR (3Y) %	11.38	10.68	11.19	13.26	11.84	10.59	6.62	8.52
Net income CAGR (3Y) %	25.21	24.42	30.27	25.48	16.66	13.25	6.03	15.98
FCF CAGR (3Y) %	25.90	3.50	22.13	31.90	8.12	12.68	7.86	39.53

Line item	2025-03	2025-06	2025-09	2025-12	2026-03	2026-06
ROE %	59.33	64.87	64.63	66.20	72.92	74.21
ROA %	27.26	29.22	30.50	31.89	33.19	33.65
ROIC %	35.45	37.71	39.83	42.15	43.51	43.22
5-year avg ROE %	--	--	--	--	--	--
EBIT margin %	29.39	31.25	31.45	31.67	31.68	32.11
FCF / sales %	21.31	19.18	22.56	24.25	24.02	27.17
Current ratio	1.16	1.11	1.18	1.23	1.12	1.17
Quick ratio	0.68	0.68	0.74	0.76	0.69	0.73
Debt / assets	32.96	37.15	32.86	29.13	32.65	31.84
LT debt / equity	37.76	38.21	30.83	29.65	25.62	24.83
Interest coverage	37.32	36.92	35.29	35.08	36.18	38.70
Revenue CAGR (3Y) %	--	--	--	--	--	--
Net income CAGR (3Y) %	--	--	--	--	--	--
FCF CAGR (3Y) %	--	--	--	--	--	--

✦ Quant Revenue Concentration how this is computed

Single-engine

Companion Animal Group (CAG) is the largest reported line at 92.39% of revenue, across 4 reported segments.
The next-largest line, Water, is a distant second at 4.41% - a sharp slowdown here would have little to offset it.

Revenue breakdown most recent period

Business

Companion Animal Group (CAG)92.39%

Water4.41%

Livestock, Poultry and Dairy (LPD)2.85%

Other revenue0.35%

Quote time 2026-10-08 05:47:24 · For reference only, not investment advice and not tailored to your situation.